GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (FRA:31R) » Definitions » Forward Dividend Yield %

Revive Therapeutics (FRA:31R) Forward Dividend Yield % : 0.00% (As of Dec. 11, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Revive Therapeutics Forward Dividend Yield %?

As of today (2024-12-11), the Forward Annual Dividend Yield of Revive Therapeutics is 0.00%.

As of today (2024-12-11), the Trailing Annual Dividend Yield of Revive Therapeutics is 0.00%.

FRA:31R's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.855
* Ranked among companies with meaningful Forward Dividend Yield % only.

Revive Therapeutics's Dividends per Share for the three months ended in Sep. 2024 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Revive Therapeutics's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Revive Therapeutics's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revive Therapeutics's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Revive Therapeutics's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Revive Therapeutics's Forward Dividend Yield % falls into.



Revive Therapeutics Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Revive Therapeutics  (FRA:31R) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Revive Therapeutics Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Revive Therapeutics's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Revive Therapeutics Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C 1P1
Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care. Currently, the Company is exploring the use of Bucillamine for the potential treatment of public health medical emergencies and rare inflammatory disorders. Revive is also advancing the development of Psilocybin-based therapeutics through various program.

Revive Therapeutics Headlines

No Headlines